Abstract
No public abstract is available from the verified source records.
Martine Extermann, Ulrich Wedding
Abstract
Authors
Institutions
Provenance
crossref
Confidence 100%
ror
Confidence 99%
openalex
Confidence 95%
unpaywall
Confidence 95%
No local citing links have been materialized yet.
Use of comprehensive geriatric assessment in older cancer patients: recommendations from the task force on CGA of the International Society of Geriatric Oncology (SIOG)
10.1016/j.critrevonc.2005.06.003 · 2005
Unresolved referenced work
Kept as external metadata until matched
Cancer screening in elderly patients: a framework for individualized decision making
10.1001/jama.285.21.2750 · 2001
Management of cancer in the older person: a practical approach
10.1634/theoncologist.5-3-224 · 2000
Basic Assessment of the Older Cancer Patient
10.1007/s11864-011-0161-5 · 2011
A specialized home care intervention improves survival among older post-surgical cancer patients
10.1111/j.1532-5415.2000.tb03886.x · 2000
Comprehensive Geriatric Assessment in the Decision-Making Process in Elderly Patients With Cancer: ELCAPA Study
10.1200/jco.2010.31.0664 · 2011
A comprehensive geriatric intervention detects multiple problems in older breast cancer patients
10.1016/s1040-8428(03)00099-4 · 2004
Shall we operate? Preoperative assessment in elderly cancer patients (PACE) can help. A SIOG surgical task force prospective study
datacite
Confidence 0%
10.1016/j.critrevonc.2007.11.001 · 2008
The role of comprehensive geriatric assessement (CGA) in the management of stage 3 hepatocellular carcinoma in the elderly
2006
Comprehensive geriatric assessment predicts tolerance to chemotherapy and survival in elderly patients with advanced ovarian carcinoma: a GINECO study
10.1093/annonc/mdi368 · 2005
Predicting falls in older patients using components of a comprehensive geriatric assessment
10.1188/08.cjon.941-949 · 2008
A new method of classifying prognostic comorbidity in longitudinal studies: development and validation
10.1016/0021-9681(87)90171-8 · 1987
Rating chronic medical illness burden in geropsychiatric practice and research: application of the Cumulative Illness Rating Scale
10.1016/0165-1781(92)90005-n · 1992
Measuring comorbidity in older cancer patients
10.1016/s0959-8049(99)00319-6 · 2000
Age, severe comorbidity and functional impairment independently contribute to poor survival in cancer patients
10.1007/s00432-007-0233-x · 2007
Effect of comorbidity and age on survival in 73 patients with de novo acute leukemia
1995
Comorbidity is an independent predictor of complete remission in elderly patients receiving induction chemotherapy for acute myeloid leukemia
10.1002/cncr.22537 · 2007
Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT
10.1182/blood-2005-05-2004 · 2005
Treating octogenarian and nonagenarian acute myeloid leukemia patients—predictive prognostic models
10.1002/cncr.24285 · 2009
Comorbidity as prognostic variable in MDS: comparative evaluation of the HCT-CI and CCI in a core dataset of 419 patients of the Austrian MDS Study Group
10.1093/annonc/mdp258 · 2010
Results of comprehensive geriatric assessment effect survival in patients with malignant lymphoma
10.1007/s00432-010-0933-5 · 2011
A comprehensive geriatric assessment is more effective than clinical judgment to identify elderly diffuse large cell lymphoma patients who benefit from aggressive therapy
10.1002/cncr.24490 · 2009
Comorbid conditions and survival in unselected, newly diagnosed patients with chronic lymphocytic leukemia
10.1080/10428190701724785 · 2008
Assessment of outcome over a 10-year period of patients admitted to a multidisciplinary adult intensive care unit with haematological and solid tumours
10.1177/0310057x0503300105 · 2005
Population-based assessment of hospitalizations for neutropenia from chemotherapy in older adults with non-Hodgkin's lymphoma (United States)
10.1007/s10552-005-0502-4 · 2006
Risk and timing of hospitalization for febrile neutropenia in patients receiving CHOP, CHOP-R, or CNOP chemotherapy for intermediate-grade non-Hodgkin lymphoma
10.1002/cncr.11827 · 2003
Comparative effectiveness of white blood cell growth factors on neutropenia, infection, and survival in older people with non-Hodgkin's lymphoma treated with chemotherapy
10.1111/j.1532-5415.2010.03081.x · 2010
Hyperglycemia During Chemotherapy for Hematologic and Solid Tumors Is Correlated With Increased Toxicity
10.1097/coc.0b013e3181e1d0c0 · 2011
Quality of life in chronic lymphocytic leukemia: an international survey of 1482 patients
10.1111/j.1365-2141.2007.06791.x · 2007
Co-morbidity and functional deficits independently contribute to quality of life before chemotherapy in elderly cancer patients
10.1007/s00520-007-0228-9 · 2007
Independent prognostic effect of co-morbidity in lymphoma patients: results of the population-based Eindhoven Cancer Registry
10.1016/j.ejca.2005.01.010 · 2005
Addition of rituximab to fludarabine and cyclophosphamide in patients with chronic lymphocytic leukaemia: a randomised, open-label, phase 3 trial
10.1016/s0140-6736(10)61381-5 · 2010
Comorbidities, not age, impact outcomes in autologous stem cell transplant for relapsed non-Hodgkin lymphoma
10.1016/j.bbmt.2008.05.002 · 2008
Utility of comorbidity assessment in predicting transplantation-related toxicity following autologous hematopoietic stem cell transplantation for multiple myeloma
10.1016/j.bbmt.2008.06.019 · 2008
Performance status and comorbidity predict transplant-related mortality after allogeneic hematopoietic cell transplantation
10.1016/j.bbmt.2006.05.015 · 2006
Assessment of the hematopoietic cell transplantation comorbidity index in non-Hodgkin lymphoma patients receiving reduced-intensity allogeneic hematopoietic stem cell transplantation
10.1016/j.bbmt.2008.11.023 · 2009
The hematopoietic cell transplantation comorbidity index (HCT-CI) predicts clinical outcomes in lymphoma and myeloma patients after reduced-intensity or non-myeloablative allogeneic stem cell transplantation
10.1038/leu.2009.1 · 2009
Age and acute myeloid leukemia: real world data on decision to treat and outcomes from the Swedish Acute Leukemia Registry
10.1182/blood-2008-07-172007 · 2009
On the value of intensive remission-induction chemotherapy in elderly patients of 65+ years with acute myeloid leukemia: a randomized phase III study of the European Organization for Research and Treatment of Cancer Leukemia Group
10.1200/jco.1989.7.9.1268 · 1989
Can first cycle CBCs predict older patients at very low risk of neutropenia during further chemotherapy?
10.1016/j.critrevonc.2010.07.001 · doi-reference
Baseline and early lymphopenia predict for the risk of febrile neutropenia after chemotherapy
10.1038/sj.bjc.6600724 · doi-reference
CD4 lymphopenia as a risk factor for febrile neutropenia and early death after cytotoxic chemotherapy in adult patients with cancer
10.1002/cncr.20688 · doi-reference
Early lymphopenia after cytotoxic chemotherapy as a risk factor for febrile neutropenia
10.1200/jco.1996.14.2.636 · doi-reference
A predictive model for life-threatening neutropenia and febrile neutropenia after the first course of CHOP chemotherapy in patients with aggressive non-Hodgkin's lymphoma
10.3109/10428190009089435 · doi-reference
MAX2—a convenient index to estimate the average per patient risk for chemotherapy toxicity; validation in ECOG trials
10.1016/j.ejca.2004.01.028 · doi-reference
Predicting the risk of chemotherapy toxicity in older patients: The Chemotherapy Risk Assessment Scale for High-Age Patients (CRASH) score
10.1002/cncr.26646 · doi-reference
Predicting chemotherapy toxicity in older adults with cancer: a prospective multicenter study
10.1200/jco.2011.34.7625 · doi-reference
Comprehensive geriatric assessment-adapted chemotherapy in elderly patients (>70 years) with diffuse large cell B cell non-Hodgkin's lymphoma (DLCBL): final results and long term follow-up
10.1182/blood.v114.22.2684.2684 · doi-reference
Management of breast cancer in the older woman
10.1177/107327480100800507 · doi-reference
Vinorelbine and prednisone in frail elderly patients with intermediate-high grade non-Hodgkin's lymphomas
10.1093/annonc/mdi243 · doi-reference
Patterns of care and survival in cancer patients with cognitive impairment
10.1016/j.critrevonc.2009.07.002 · doi-reference
Impairment in functional status and survival in patients with acute myeloid leukaemia
10.1007/s00432-006-0115-7 · doi-reference
A predictive model for aggressive non-Hodgkin's lymphoma. The International Non-Hodgkin's Lymphoma Prognostic Factors Project
10.1056/nejm199309303291402 · doi-reference